The cost-effectiveness of telestroke in the treatment of acute ischemic stroke

Neurology

Volumn 77, Issue 17, 2011, Pages 1590-1598

  Nelson, R E ^a,b   Saltzman, G M ^c,d   Skalabrin, E J ^b   Demaerschalk, B M ^e   Majersik, J J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ALBION COLLEGE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUDIOVISUAL EQUIPMENT; BRAIN ISCHEMIA; COST EFFECTIVENESS ANALYSIS; EMERGENCY WARD; HEALTH CARE COST; HUMAN; MONTE CARLO METHOD; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; TELESTROKE; UNITED STATES;

EID: 82955167978     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318234332d     Document Type: Article

References (39)

1. Eberhardt MS, Pamuk ER. The importance of place of residence: examining health in rural and nonrural areas. Am J Public Health 2004;94:1682-1686. (Pubitemid 39331751)
2. Pearson TA, Lewis C. Rural epidemiology: insights from a rural population laboratory. Am J Epidemiol 1998;148: 949-957. (Pubitemid 28533734)
3. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711.
4. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-2948.
5. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke 2009;40: 3580-3584.
6. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 2001;56: 1015-1020. (Pubitemid 32336306)
7. Switzer JA, Hall C, Gross H, et al. A web-based telestroke system facilitates rapid treatment of acute ischemic stroke patients in rural emergency departments. J Emerg Med 2009;36:12-18.
8. Moskowitz A, Chan YF, Bruns J, Levine SR. Emergency physician and stroke specialist beliefs and expectations regarding telestroke. Stroke 2010;41:805-809.
9. Demaerschalk BM, Hwang HM, Leung G. Cost analysis review of stroke centers, telestroke, and rt-PA. Am J Manag Care 2010;16:537-544.
10. Silva GS, Viswanathan A, Shandra E, Schwamm LH. Telestroke 2010: a survey of currently active stroke telemedicine programs in the US. Stroke 2011;42:e292.
11. Quinn TJ, Dawson J, Walters MR, Lees KR. Exploring the reliability of the modified Rankin scale. Stroke 2009; 40:762-766.
12. Lai SM, Duncan PW. Stroke recovery profile and the modified Rankin assessment. Neuroepidemiology 2001; 20:26-30. (Pubitemid 32171135)
13. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008;39:924-928. (Pubitemid 351619542)
14. Ickenstein GW, Horn M, Schenkel J, et al. The use of telemedicine in combination with a new stroke-code-box significantly increases t-PA use in rural communities. Neurocrit Care 2005;3:27-32. (Pubitemid 41278390)
15. Miley ML, Demaerschalk BM, Olmstead NL, et al. The state of emergency stroke resources and care in rural Arizona: a platform for telemedicine. Telemed J E Health 2009;15:691-699.
16. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333: 1581-1587.
17. Schwab S, Vatankhah B, Kukla C, et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007;69:898-903. (Pubitemid 47329590)
18. Earnshaw SR, Jackson D, Farkouh R, Schwamm L. Costeffectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis. Stroke 2009;40:1710-1720.
19. Brown DL, Boden-Albala B, Langa KM, et al. Projected costs of ischemic stroke in the United States. Neurology 2006;67:1390-1395. (Pubitemid 44632062)
20. Silbergleit R, Scott PA, Lowell MJ. Cost-effectiveness of helicopter transport of stroke patients for thrombolysis. Acad Emerg Med 2003;10:966-972. (Pubitemid 37093200)
21. Russo CA, Andrews RM. Hospital stays for stroke and other cerebrovascular diseases. In: Healthcare Cost and Utilization Project. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
22. Deutsch A, Granger CV, Heinemann AW, et al. Poststroke rehabilitation: outcomes and reimbursement of inpatient rehabilitation facilities and subacute rehabilitation programs. Stroke 2006;37:1477-1482. (Pubitemid 44305729)
23. Hickenbottom SL, Fendrick AM, Kutcher JS, Kabeto MU, Katz SJ, Langa KM. A national study of the quantity and cost of informal caregiving for the elderly with stroke. Neurology 2002;58:1754-1759. (Pubitemid 34663573)
24. Lee WC, Christensen MC, Joshi AV, Pashos CL. Longterm cost of stroke subtypes among Medicare beneficiaries. Cerebrovasc Dis 2007;23:57-65. (Pubitemid 46112803)
25. Schlegel D, Kolb SJ, Luciano JM, et al. Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke 2003;34:134-137. (Pubitemid 36070814)
26. Gage BF, Cardinalli AB, Owens DK. Cost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation. Stroke 1998;29:1083-1091. (Pubitemid 28265459)
27. Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Costeffectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke 2006;37: 2751-2758. (Pubitemid 44929415)
28. Samsa GP, Reutter RA, Parmigiani G, et al. Performing cost-effectiveness analysis by integrating randomized trial data with a comprehensive decision model: application to treatment of acute ischemic stroke. J Clin Epidemiol 1999; 52:259-271. (Pubitemid 29148438)
29. Grosse SD. Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold. Expert Rev Pharmacoecon Outcomes Res 2008;8:165-178. (Pubitemid 351959547)
30. Braithwaite RS, Meltzer DO, King JT Jr, Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med Care 2008;46:349-356.
31. Fenwick E, Marshall DA, Levy AR, Nichol G. Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation. BMC Health Serv Res 2006;6:52.
32. de Bustos EM, Moulin T, Audebert HJ. Barriers, legal issues, limitations and ongoing questions in telemedicine applied to stroke. Cerebrovasc Dis 2009;27(suppl 4):36-39.
33. Leira EC, Hess DC, Torner JC, Adams HP Jr. Ruralurban differences in acute stroke management practices: a modifiable disparity. Arch Neurol 2008;65:887-891. (Pubitemid 352008471)
34. Demaerschalk BM, Miley ML, Kiernan TE, et al. Stroke telemedicine. Mayo Clin Proc 2009;84:53-64.
35. Meurer WJ, Frederiksen SM, Majersik JJ, Zhang L, Sandretto A, Scott PA. Qualitative data collection and analysis methods: the INSTINCT trial. Acad Emerg Med 2007; 14:1064-1071. (Pubitemid 47615472)
36. Frey JL, Jahnke HK, Goslar PW, Partovi S, Flaster MS. tPA by telephone: extending the benefits of a comprehensive stroke center. Neurology 2005;64:154-156. (Pubitemid 40082958)
37. Meyer BC, Raman R, Hemmen T, et al. Efficacy of siteindependent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008;7:787-795.
38. Fagan SC, Morgenstern LB, Petitta A, et al. Costeffectiveness of tissue plasminogen activator for acute ischemic stroke: NINDS rt-PA Stroke Study Group. Neurology 1998;50:883-890. (Pubitemid 28212810)
39. Kraus MR, Schafer A, Csef H, Faller H, Mork H, Scheurlen M. Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci 2001;46:2060-2065. (Pubitemid 32955211)